FDA Clearance Tracker · P030016-S042
EVO/EVO+ VISIAN® Implantable Collamer® Lenses
Last checked: Nov 20, 2026Latest source record: May 20, 2022 (this decision)Source: openFDAMethods & limitations
Decided
May 20, 2022
Approved
Time to decision
46 days
Received Apr 4, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P030016-S042
- Device name
- EVO/EVO+ VISIAN® Implantable Collamer® Lenses
- Applicant
- STAAR Surgical Company
- Applicant location
- Monrovia, CA
- Received
- Apr 4, 2022
- Decided
- May 20, 2022
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol
- Original approval
- P030016
Device type
- Device type
- Lens, intraocular, phakic (MTA)
- Device class
- Class III
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Approval of the protocol for the post-approval study (PAS) protocol.
Source documents
Other decisions for STAAR Surgical Company
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- EVO/EVO+VISIAN Implantable Collamer LensPMA supplement
P030016-S035 · Decided Mar 25, 2022 · 1,240 days after receipt · Panel Track
Device type: Lens, intraocular, phakic (MTA) · Ophthalmology
3 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.